{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:04:41Z","timestamp":1791497081633,"version":"4.3.4"},"reference-count":31,"publisher":"Japan Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1507\/endocrj.ej21-0266","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T22:08:42Z","timestamp":1630620522000},"page":"115-120","source":"Crossref","is-referenced-by-count":4,"title":["Identification of a homozygous c.1039C>T (p.R347C) variant in <i>CYP17A1<\/i> in a 67-year-old female patient with partial 17\u03b1-hydroxylase\/17,20-lyase deficiency"],"prefix":"10.1507","volume":"69","author":[{"given":"Satoshi","family":"Yamagata","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kageyama","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Usui","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Shizuoka General Hospital, Shizuoka 420-8527, Japan"},{"name":"Shizuoka Graduate University of Public Health, Shizuoka 420-0881, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Shizuoka General Hospital, Shizuoka 420-8527, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Takayasu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Usutani","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Terui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Daimon","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 New MI (2003) Inborn errors of adrenal steroidogenesis. Mol Cell Endocrinol 211: 75\u201383.","DOI":"10.1016\/j.mce.2003.09.013"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Yanase T, Simpson ER, Waterman MR (1991) 17 alpha-hydroxylase\/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 12: 91\u2013108.","DOI":"10.1210\/edrv-12-1-91"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Auchus RJ (2017) Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic. J Steroid Biochem Mol Biol 165: 71\u201378.","DOI":"10.1016\/j.jsbmb.2016.02.002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Biglieri EG, Kater CE (1991) 17 alpha-hydroxylation deficiency. Endocrinol Metab Clin North Am 20: 257\u2013268.","DOI":"10.1016\/S0889-8529(18)30267-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Katayama Y, Kado S, Wada S, Nemoto Y, Kugai N, et al. (1994) A case of 17\u03b1-hydroxylase deficiency with retained menstruation. Endocr J 41: 213\u2013218.","DOI":"10.1507\/endocrj.41.213"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Ueda Y, Usui T, Watanabe T, Kaneko K, Nakatani R, et al. (2015) Elevated levels of plasma immunoassayable aldosterone in a mild form of 17 alpha-hydroxylase\/17,20-lyase deficiency diagnosed at the age of 50. AACE Clin Case Rep 1: e156\u2013e160.","DOI":"10.4158\/EP14388.CR"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, et al. (2011) Guidelines for the diagnosis and treatment of primary aldosteronism\u2014the Japan Endocrine Society 2009. Endocr J 58: 711\u2013721.","DOI":"10.1507\/endocrj.EJ11-0133"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Usui T, Nishisho K, Kaji M, Ikuno N, Yorifuji T, et al. (2004) Three novel mutations in Japanese patients with 21-hydroxylase deficiency. Horm Res 61: 126\u2013132.","DOI":"10.1159\/000075587"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Van Den Akker EL, Koper JW, Boehmer AL, Themmen AP, Verhoef-Post M, et al. (2002) Differential inhibition of 17\u03b1-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency. J Clin Endocrinol Metab 87: 5714\u20135721.","DOI":"10.1210\/jc.2001-011880"},{"key":"10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/dna.1987.6.439","volume":"6","author":"J Picado-Leonard","year":"1987","unstructured":"10 Picado-Leonard J, Miller WL (1987) Cloning and sequence of the human gene for P450c17 (steroid 17 alpha-hydroxylase\/17,20 lyase): similarity with the gene for P450c21. DNA 6: 439\u2013448.","journal-title":"DNA","ISSN":"https:\/\/id.crossref.org\/issn\/0198-0238","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Sparkes RS, Klisak I, Miller WL (1991) Regional mapping of genes encoding human steroidogenic enzymes: P450scc to 15q23-q24, adrenodoxin to 11q22; adrenodoxin reductase to 17q24-q25; and P450c17 to 10q24-q25. DNA Cell Biol 10: 359\u2013365.","DOI":"10.1089\/dna.1991.10.359"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Turkkahraman D, Guran T, Ivison H, Griffin A, Vijzelaar R, et al. (2015) Identification of a novel large CYP17A1 deletion by MLPA analysis in a family with classic 17\u03b1-hydroxylase deficiency. Sex Dev 9: 91\u201397.","DOI":"10.1159\/000375183"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Bolu S, Er\u00f6z R, Tekin M, Do\u011fan M (2020) Atypical presentation in patients with 17 \u03b1-hydroxylase deficiency caused by a deletion in the CYP17A1 gene: short stature. Turk J Pediatr 62: 851\u2013857.","DOI":"10.24953\/turkjped.2020.05.019"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Kardelen AD, Toksoy G, Ba\u015f F, Yava\u015f Abal\u0131 Z, Gen\u00e7ay G, et al. (2018) A rare cause of congenital adrenal hyperplasia: clinical and genetic findings and follow-up characteristics of six patients with 17-hydroxylase deficiency including two novel mutations. J Clin Res Pediatr Endocrinol 10: 206\u2013215.","DOI":"10.4274\/jcrpe.0032"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Nakajin S, Shinoda M, Haniu M, Shively JE, Hall PF (1984) C21 steroid side chain cleavage enzyme from porcine adrenal microsomes. Purification and characterization of the 17 alpha-hydroxylase\/C17,20-lyase cytochrome P-450. J Biol Chem 259: 3971\u20133976.","DOI":"10.1016\/S0021-9258(17)43191-7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Auchus RJ (2001) The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin North Am 30: 101\u2013119, vii.","DOI":"10.1016\/S0889-8529(08)70021-5"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Yamakita N, Murase H, Yasuda K, Noritake N, Mercado-Asis LB, et al. (1989) Possible hyperaldosteronism and discrepancy in enzyme activity deficiency in adrenal and gonadal glands in Japanese patients with 17 alpha-hydroxylase deficiency. Endocrinol Jpn 36: 515\u2013536.","DOI":"10.1507\/endocrj1954.36.515"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Costa-Santos, M, Kater CE, Auchus RJ, Brazilian Congenital Adrenal Hyperplasia Multicenter Study Group (2004) Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency. J Clin Endocrinol Metab 89: 49\u201360.","DOI":"10.1210\/jc.2003-031021"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Kater CE, Biglieri EG (1994) Disorders of steroid 17 alpha-hydroxylase deficiency. Endocrinol Metab Clin North Am 23: 341\u2013357.","DOI":"10.1016\/S0889-8529(18)30101-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Bassett MH, White PC, Rainey WE (2004) The regulation of aldosterone synthase expression. Mol Cell Endocrinol 217: 67\u201374.","DOI":"10.1016\/j.mce.2003.10.011"},{"key":"21","unstructured":"21 Method-sheet-cobas [Internet]. Roche Diagnostics GmbH, Mannheim. Available from: http:\/\/labogids.sintmaria.be\/sites\/default\/files\/files\/cortisol_ii_2017-05_v4.pdf accessed on June 24, 2021"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Newell-Price J, Morris DG, Drake WM, Korbonits M, Monson JP, et al. (2002) Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing\u2019s syndrome. J Clin Endocrinol Metab 87: 1640\u20131645.","DOI":"10.1210\/jcem.87.4.8357"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Miura K, Yasuda K, Yanase T, Yamakita N, Sasano H, et al. (1996) Mutation of cytochrome P-45017 alpha gene (CYP17) in a Japanese patient previously reported as having glucocorticoid-responsive hyperaldosteronism: with a review of Japanese patients with mutations of CYP17. J Clin Endocrinol Metab 81: 3797\u20133801.","DOI":"10.1210\/jcem.81.10.8855840"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Geller DH, Auchus RJ, Mendon\u00e7a BB, Miller WL (1997) The genetic and functional basis of isolated 17,20 lyase deficiency. Nat Genet 17: 201\u2013205.","DOI":"10.1038\/ng1097-201"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Auchus RJ, Miller WL (1999) Molecular modeling of human P450c17 (17alpha-hydroxylase\/17,20-lyase): insights into reaction mechanisms and effects of mutations. Mol Endocrinol 13: 1169\u20131182.","DOI":"10.1210\/me.13.7.1169"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Geller DH, Auchus RJ, Miller WL (1999) P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5. Mol Endocrinol 13: 167\u2013175.","DOI":"10.1210\/mend.13.1.0219"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27 Miller WL (2005) Minireview: regulation of steroidogenesis by electron transfer. Endocrinology 146: 2544\u20132550.","DOI":"10.1210\/en.2005-0096"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Naffin-Olivos JL, Auchus RJ (2006) Human cytochrome b5 requires residues E48 and E49 to stimulate the 17, 20-lyase activity of cytochrome P450c17. Biochemistry 45: 755\u2013762.","DOI":"10.1021\/bi051623y"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Peng HM, Liu J, Forsberg SE, Tran HT, Anderson SM, et al. (2014) Catalytically relevant electrostatic interactions of cytochrome P450c17 (CYP17A1) and cytochrome b5. J Biol Chem 289: 33838\u201333849.","DOI":"10.1074\/jbc.M114.608919"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Lee-Robichaud P, Akhtar ME, Wright JN, Sheikh QI, Akhtar M (2004) The cationic charges on Arg347, Arg358, and Arg449 of human cytochrome P450c17 (CYP17) are essential for the enzyme\u2019s cytochrome b5-dependent acyl-carbon cleavage activities. J Steroid Biochem Mol Biol 92: 119\u2013130.","DOI":"10.1016\/j.jsbmb.2004.07.005"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Auchus RJ, Lee TC, Miller WL (1998) Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. J Biol Chem 273: 3158\u20133165.","DOI":"10.1074\/jbc.273.6.3158"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/69\/2\/69_EJ21-0266\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:21:47Z","timestamp":1715232107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/69\/2\/69_EJ21-0266\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej21-0266","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"EJ21-0266"}}